jakavi
novartis europharm limited - ruxolitinib (som phosphat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastiske midler - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi er indiceret til behandling af voksne patienter med polycythaemia vera, som er resistente over for eller intolerante over for hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.
lodin 200 ec flydende middel
agrichem b. v. - fluroxypyr - flydende middel - 200 g/l fluroxypyr
inter-pendimethalin 330 emulsionskoncentrat
inter-trade a/s - pendimethalin - emulsionskoncentrat - 330 g/l pendimethalin
reglone, reg.nr. 1-178 vandopløseligt koncentrat
syngenta nordics a/s - diquat, diquat - vandopløseligt koncentrat - 374 g/l diquat dibromid ; (~ 200 g/l diquat
stomp suspensionskoncentrat
basf a/s - pendimethalin - suspensionskoncentrat - 400 g/l pendimethalin
plenum 50 wg vanddispergerbart granulat
syngenta nordics a/s - pymetrozin - vanddispergerbart granulat - 500 g/kg pymetrozin
armure emulsionskoncentrat
syngenta nordics a/s - difenoconazol, propiconazol - emulsionskoncentrat - 150 g/l difenoconazol ; 150 g/l propiconazol
osiris emulsionskoncentrat
basf a/s - metconazol, epoxiconazol - emulsionskoncentrat - 27,5 g/l metconazol ; 37,5 g/l epoxiconazol
shirlan suspensionskoncentrat
syngenta nordics a/s - fluazinam - suspensionskoncentrat - 500 g/l fluazinam
designer flydende middel
de sangosse ltd. - sprede-klæbemiddel - flydende middel - 1000 g/l sprede-klæbemiddel